7 Blue-Chip Stocks With Dividends to Add to Your Q2 Buy List

  • Here are seven of the best blue-chip stocks with dividends to boost your portfolio in these testing economic times.
  • IBM (IBM): The new-look business is focusing on profitable areas in the software space.
  • Lockheed Martin (LMT): The war in Ukraine will bode incredibly well for its international business.
  • PepsiCo (PEP): Evergreen brands and a robust cost structure will help navigate the rough climate.
  • The TJX Companies (TJX): Rampant inflation rates should drive customers to discount retailers.
  • Lumen Technologies (LUMN): Fiber-optics business presents an amazing growth runway ahead.
  • McDonald’s (MCD): The push towards delivery and digital has been a revelation in the past couple of years.
  • Merck’s (MRK): Dividend king with an incredible product portfolio.
Blue Chip Stocks With Dividends - 7 Blue-Chip Stocks With Dividends to Add to Your Q2 Buy List

Source: Shutterstock

Investing in blue-chip stocks with dividends is a match made in heaven. Blue-chip stocks have had a history of producing market-beating returns, and if you blend them with dividends, there’s nothing like it. Investors who are looking for steady returns and minimizing their risk should opt for blue-chip stocks that offer dividends.

Investing in the biggest, strongest companies — known as blue-chip stocks — is a great way to earn solid returns with low downside risk. Blue-chip stocks belong to high-quality companies that are typically leaders in their sector. With incredible fundamentals, their stocks offer strong price returns to investors. Not all pay dividends, though, but such a combination is tailor-made for the current macroeconomic environment.

Here are seven such stocks to add to your buy list.

IBM IBM $140.81
LMT Lockheed Martin $442.11
PEP PepsiCo $166.42
TJX The TJX Companies $63.25
LUMN Lumen Technologies $11.78
MCD McDonald’s $249.17
MRK Merck $90.35


Photo of IBM (IBM) building as seen through the canopy of a tree. IBM logo is in large letters on side of building.

Source: shutterstock.com/LCV

Tech stocks have taken hiding in recent months, but IBM (NYSE:IBM) stock has been an anomaly. It gained a healthy 21% value in the past six months due to a relatively impressive operating performance. Moreover, it offers a highly attractive dividend with close to a 70% payout rate and a 4.74% yield.

IBM’s first-quarter results show a strong 8% jump in sales. It’s the first quarter for the new-look IBM, which completed its multi-year effort to transform its business. It believes it can continue growing revenues rapidly through its software business focusing on AI and cloud computing. Moreover, its sizeable consultancy business also generates an impressive $4.8 billion in sales during the first quarter, a 17% increase on a year-over-year basis.

Lockheed Martin (LMT)

A Lockheed Martin (LMT) Space Systems sign in Sunnyvale, California.

Source: Ken Wolter / Shutterstock.com

Lockheed Martin (NYSE:LMT) is the largest defense contractor for the U.S. armed forces, which means its top customer has the deepest pockets. It has established itself as a clear leader in the industry with reliable income streams, remarkably consistent results, and the ability to withstand economic slowdowns. It boasts an enviable dividend profile, with 20 years of growth in payouts and an eye-catching yield of roughly 2.5%.

The ongoing conflict in Ukraine could potentially result in a revenue windfall in the coming years. Europe will be a key market for defense contractors, with several countries looking to beef up their defense capabilities. Finland and Sweden have indicated that they will be applying for NATO membership.

Moreover, Germany announced an upgrade to its fighter jets with a purchase of 35 F-35 fighter jets from LMT. I expect more countries in Europe to follow suit, which should offset the loss in sales from the Pentagon recently curtailing its shopping list with the company.

PepsiCo (PEP)

Cans of PepsiCo's (PEP) Pepsi soda are in a bucket of ice.

Source: suriyachan / Shutterstock.com

Snacks and beverages giant PepsiCo (NASDAQ:PEP) continues to wow the market with its innovation and ability to weather the most difficult challenges. Inflation rates are near multi-year highs as consumer confidence remains at a low ebb.

Despite these challenges, its business is thriving, indicating its strong earnings beat and a dividend raise of 7 cents per quarter to $4.60 annually. It now offers an attractive forward dividend yield of 2.8%.

PepsiCo’s timeless brands have allowed it to effectively navigate the current macro-economic crisis. Despite supply chain pressures and a pullout from Russia, the company’s earnings per share during the first quarter shot up from $1.21 last year to $1.29 this year.

The encouraging result was due to effective cost and price management. Hence, its robust branding ability and pricing power make the stock an effective hedge against inflation.

The TJX Companies (TJX)

An outside shot of a T.J. Maxx (TJX) store in Romeoville, Illinois.

Source: Joe Hendrickson / Shutterstock.com

The TJX Companies (NYSE:TJX) is a leading discount retailer with a proven track record of sustained sales and earnings growth. It’s been posting a steady increase in sales and profit gains over the past three decades, and its stock has performed well too.

The pandemic shut down the bulk of its stores, which severely impacted its results. However, the re-opening tailwinds will likely spark a comeback for the business in the upcoming quarters. Moreover, consumers are likely to favor discount retailers such as TJX amidst the inflationary pressures.

Its management is confident of better prospects ahead with higher-margin cash flows and sales growth over the next few quarters. Additionally, it has a $7 billion inventory on hand, compared to roughly $5 billion a year ago, which positions it incredibly well for the summer season. TJX stock offers a reasonable dividend payout to further sweeten the deal, with a 1.9% yield.

Lumen Technologies (LUMN)

Person holding mobile phone with logo of American telecom company Lumen Technologies Inc. on screen in front of web page

Source: T. Schneider via Shutterstock

Lumen Technologies (NYSE:LUMN)  is a telecom operator, similar to its peers, transitioning from traditional landline service to more advanced offerings such as fiber optics. The goal is to offer robust connectivity by expanding fiber optics capability and investments in other architectures.

LUMN stock trades at an attractive valuation under one-time forward sales, with a dividend yield of 8.5%. The beauty of the enterprise is that its dividend is covered purely through cash flows.

Lumen recently increased its free cash flow and EBITDA (earnings before interest, taxation, depreciation and amortization) guidance by $400 million. It now expects FCF to be at $2 billion to $2.2 billion while its adjusted EBITDA to fall in the $6.9 billion to $7.1 billion range. Its fiber business has been experiencing incredible growth of late and is likely to dictate its future direction.

McDonald’s (MCD)

McDonald's (MCD) building with logo at sunset

Source: ATIKAN PORNCHAIPRASIT / Shutterstock.com

McDonald’s (NYSE:MCD) is one of the most popular fast-food chains globally. Despite stiff competition and market saturation, it remains one of the juggernauts in the sector. It offers strong upside potential with its ability to outperform competitors in tough environments. Moreover, it boasts a spectacular dividend profile with a yield of 2.2% and 13 years of growth.

McDonald’s restaurants generate over $100 billion in sales each year, with no one closing close to its dominance. In the past couple of years, it benefitted from the push towards digital and home-delivery niches.

Its recently released first-quarter results showed 20.4% and 3.5% growth in Global and U.S. same-store sales, respectively. Additionally, digital sales comprised over 30% of system-wide sales for MCD’s top six markets.

Merck’s (MRK)

Source: JHVEPhoto / Shutterstock.com

Merck’s (NYSE:MRK) is one of the leading pharmaceutical giants with an extensive oncology portfolio. There are several drugs in its portfolio, including several cancer-fighting drugs, including Keytruda, Lenvima and others. These medicines offer solid competitive advantages, which brought over $5 billion in sales in the first quarter, representing 25% growth from the same quarter last year.

Experts project Merck is in for an incredible time ahead with the approval of multiple therapies. Apart from its cancer drugs, Merck’s human papillomavirus vaccine, Gardasil, and the recently released coronavirus pill, Lagevrio, could potentially rake in billions in sales.

The company has increased its dividend for the past 12 years, and its CFO Caroline Litchfield states that the company is committed to increasing its dividend over time.

On the publication date, Muslim Farooque did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.

Muslim Farooque is a keen investor and an optimist at heart. A life-long gamer and tech enthusiast, he has a particular affinity for analyzing technology stocks. Muslim holds a bachelor’s of science degree in applied accounting from Oxford Brookes University.

Article printed from InvestorPlace Media, https://investorplace.com/2022/06/7-blue-chip-stocks-with-dividends-to-add-to-your-q2-buy-list/.

©2023 InvestorPlace Media, LLC